FDA chief to depart after Trump signed off on ousting him

FDA Leadership Shift as Trump Approves Makary’s Resignation

FDA chief to depart after Trump – Marty Makary, the head of the Food and Drug Administration, is set to exit the Trump administration, as confirmed by three individuals close to the situation, following President Donald Trump’s approval of a plan to dismiss him last week. His departure marks a significant change in the agency’s leadership, reflecting growing tensions between the FDA and the White House over key policy decisions and internal management dynamics.

Makary’s tenure has been defined by persistent friction with both internal and external forces within the administration. His resistance to approving the sale of flavored e-cigarettes became a focal point of this discord, prompting Trump to confront him directly on the issue. This clash, combined with pressure from pharmaceutical companies and anti-abortion groups, contributed to